AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Platel, D Bonoron-Adele, S Robert, J
Citation: D. Platel et al., Role of daunorubicinol in daunorubicin-induced cardiotoxity as evaluated with the model of isolated perfused rat heart, PHARM TOX, 88(5), 2001, pp. 250-254

Authors: Laclau, MN Boudina, S Thambo, JB Tariosse, L Gouverneur, G Bonoron-Adele, S Saks, VA Garlid, KD Dos Santos, P
Citation: Mn. Laclau et al., Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase, J MOL CEL C, 33(5), 2001, pp. 947-956

Authors: Platel, D Pouna, P Bonoron-Adele, S Robert, J
Citation: D. Platel et al., Preclinical evaluation of the cardiotoxicity of taxane-anthracycline combinations using the model of isolated perfused rat heart, TOX APPL PH, 163(2), 2000, pp. 135-140

Authors: Dos Santos, P Aliev, MK Diolez, P Duclos, F Besse, P Bonoron-Adele, S Sikk, P Canioni, P Saks, VA
Citation: P. Dos Santos et al., Metabolic control of contractile performance in isolated perfused rat heart. Analysis of experimental data by reaction : diffusion mathematical model, J MOL CEL C, 32(9), 2000, pp. 1703-1734

Authors: Platel, D Pouna, P Bonoron-Adele, S Robert, J
Citation: D. Platel et al., Comparative cardiotoxicity of idarubicin and doxorubicin using the isolated perfused rat heart model, ANTI-CANC D, 10(7), 1999, pp. 671-676

Authors: Platel, D Bonoron-Adele, S Dix, RK Robert, J
Citation: D. Platel et al., Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin, BR J CANC, 81(1), 1999, pp. 24-27
Risultati: 1-6 |